MedTrace Logo

Histiocytosis and Inflammatory Manifestations in Patients with H Syndrome

NCT06742073 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 120

Last updated 2024-12-19

No results posted yet for this study

Summary

H syndrome is a rare genetic disorder predisposing to histiocytosis. Our knowledge of the clinical spectrum of these patients is based on case reports and small patient series. Patients with H syndrome have been treated with a range of immunomodulatory and chemotherapeutic agents, with limited success. We aim to comprehensively assess the clinical manifestations and patterns of treatment response in a multinational cohort of patients with H syndrome.

Conditions

  • H Syndrome

Sponsors & Collaborators

  • Rabin Medical Center

    lead OTHER

Principal Investigators

  • Sarah Elitzur, MD · Schneider Children'ds Medical Center

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-11-01
Primary Completion
2026-07-01
Completion
2026-08-01

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06742073 on ClinicalTrials.gov